This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Enud Erik Andersen: Innovator in Azaheterocyclic Carboxylic Acids
Introduction
Enud Erik Andersen is a notable inventor based in Smørum, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of N-substituted azaheterocyclic carboxylic acids. His work has implications for various applications in pharmaceuticals and beyond.
Latest Patents
Andersen holds a patent for N-substituted azaheterocyclic carboxylic acids and their use. This patent showcases his innovative approach to chemical compounds that can be utilized in various industries. He has 1 patent to his name, reflecting his focused contributions to the field.
Career Highlights
Andersen is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His expertise in chemistry and innovation is a valuable asset to the company.
Collaborations
Throughout his career, Andersen has collaborated with esteemed colleagues such as Florenzio Zaragossa Dörwald and Rolf Hohlweg. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion
Enud Erik Andersen is a distinguished inventor whose work in N-substituted azaheterocyclic carboxylic acids has made a significant impact in the field of chemistry. His contributions at Novo Nordisk A/S and collaborations with other experts highlight his commitment to innovation and excellence.